BioHiTech Global to Present at the 2nd Annual Gabelli & Company Waste and Environmental Services Symposium on March 3, 2016

Feb 23, 2016, 08:31 ET from BioHiTech Global, Inc.

CHESTNUT RIDGE, N.Y., Feb. 23, 2016 /PRNewswire/ -- BioHiTech Global, Inc. ("BioHiTech") (OTCQB: BHTG), a green technology company that provides innovative data-driven solutions for food waste disposal, has been invited to present at the 2nd Annual Gabelli & Company Waste & Environmental Services Symposium being held on March 3, 2016 at the Andaz 5th Avenue Hotel in New York City.

BioHiTech CEO Frank E. Celli is scheduled to present on Thursday, March 3rd at 8:30 a.m. Eastern time, followed by a 20 minute Q&A fireside chat with senior management and institutional investors.

For additional information or to schedule a one-on-one meeting with BioHiTech management, please email your request to or call Chris Tyson at (949) 491-8235.

About Gabelli & Company
G.Research, LLC, an institutional research and brokerage firm, is a subsidiary of GAMCO Investors, Inc. (NYSE: GBL). Gabelli & Company is the marketing name for the registered broker dealer G.research, LLC. G.research, LLC, One Corporate Center Rye, NY 10580. Member of FINRA and SIPC. For more information, please visit

About BioHiTech Global The Company, headquartered in Chestnut Ridge NY, is a technology company that provides the transparency needed to prevent food waste as well as offer a sustainable means for its disposal.  BioHiTech's data-driven solution offers businesses insight into their waste stream creating immediate opportunities to identify inefficiencies, improve operating budgets and advance sustainability initiatives within their company.

BioHiTech Global (OTCQB: BHTG) currently has two subsidiaries including BioHiTech America, LLC and BioHiTech Europe LTD. BioHiTech Global, Inc. is a publicly traded company engaged in helping companies divert waste from landfills.

For more information, please visit

Forward Looking Statements Statements in this document contain certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, as amended. These statements are based on many assumptions and estimates and are not guarantees of future performance. These statements may involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of BioHiTech Global, Inc. to be materially different from future results, performance or achievements expressed or implied by such forward-looking statements. BioHiTech Global, Inc. assumes no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Our actual results may differ materially from the results anticipated in these forward-looking statements due to a variety of factors, including, without limitation those set forth as "Risk Factors" in our filings with the Securities and Exchange Commission ("SEC"). There may be other factors not mentioned above or included in the BioHiTech's SEC filings that may cause actual results to differ materially from those projected in any forward-looking statement. BioHiTech Global, Inc. assumes no obligation to update any forward-looking statements as a result of new information, future events or developments, except as required by securities laws.

Media Contact:

Rubenstein Public Relations Contact: Kristie Galvani Tel: 212-843-9205

Investor Relations Contact:

MZ North America Ted Haberfield President – MZ North America Direct: 760-755-2716 Mobile: 858-204-5055

Sales Contact:

BioHiTech Global, Inc. Lisa Giovannielli Marketing Director Direct: 845-262-1081

SOURCE BioHiTech Global, Inc.